Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patients

BACKGROUND: A neoadjuvant chemotherapy (NCT) is a feasible second-option other than an adjuvant chemotherapy (ACT); however, no definite conclusions have been drawn about whether or not a NCT is associated with better clinical outcomes for IIIA non-small cell lung cancer (NSCLC) patients. METHODS: W...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thorac Dis
Autori principali: Tao, Xiaoting, Yuan, Chongze, Zheng, Difan, Ye, Ting, Pan, Yunjian, Zhang, Yawei, Xiang, Jiaqing, Hu, Hong, Chen, Haiquan, Sun, Yihua
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531706/
https://ncbi.nlm.nih.gov/pubmed/31179087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.03.42
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi